Atlas Trials

A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma

Clinical trial NCT03714529 · COMPLETED

Trial details

NCT number
NCT03714529
Sponsor
Herlev and Gentofte Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Basal Cell Carcinoma
Start date
2018-11-01
Primary completion
2020-02-05
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.